15% TOPICAL RESORCINOL FOR HURLEY I-II HIDRADENITIS SUPPURATIVA.

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Status: Unknown

Conditions: HYDRADENITIS

Study type: Observational

Funder types: Other

Identifiers

NCT04099212

FIS-RES-2018-01

Details and patient eligibility

About

Prospective, observational cross-sectional study to evaluate the response of patients with HS I-II to monotherapy treatment of topical resorcin 15%, taking into account its safety, impact on quality of life and subclinical evolution.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years.
• Diagnosed with HS Hurley I-II degree.
• Patients that have at least 1 or more swollen up nodules and/or abscess.
• Availability of affected region control ultrasound prior to resorcine treatment beginning.

Exclusion criteria

• Age < 18 years.
• Number of draining fistula above 20.
• Patients in active treatment with immunomodulators.
• Patients in active treatment with antibiotics.

Trial design

40 participants in 1 patient group

Cases

Description:

Patients with HS I-II in monotherapy treatment of topical resorcinol 15%